AstraZeneca in Neutral Lane – Analyst Blog

By | September 14, 2012
0 Comment

We are maintaining our Neutral recommendation on AstraZeneca ( AZN ) with a target price of $49.00. The stock carries a Zacks #3 Rank (Hold rating) in the short run

Read this article:
AstraZeneca in Neutral Lane – Analyst Blog

Related posts:

  1. Theravance Stays Neutral – Analyst Blog
  2. Stone Energy in Neutral Lane – Analyst Blog
  3. Exelon Stays on Neutral Lane – Analyst Blog
  4. Principal in Neutral Lane – Analyst Blog